-
1 Comment
Hanmi Pharm. Co., Ltd is currently in a long term uptrend where the price is trading 3.0% above its 200 day moving average.
From a valuation standpoint, the stock is 59.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Hanmi Pharm. Co., Ltd's total revenue sank by 8.5% to $277B since the same quarter in the previous year.
Its net income has increased by 90.5% to $28B since the same quarter in the previous year.
Finally, its free cash flow grew by 4711.5% to $75B since the same quarter in the previous year.
Based on the above factors, Hanmi Pharm. Co., Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | KO |
| CurrencyCode | KRW |
| ISIN | KR7128940004 |
| Market Cap | 3T |
|---|---|
| Target Price | 353500 |
| PE Ratio | None |
| Dividend Yield | 0.5% |
| Beta | 0.64 |
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 128940.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
